News: Amgen Inc (AMGN.O)

AMGN.O on Nasdaq

161.89USD
3:43pm EDT
Price Change (% chg)

$0.31 (+0.19%)
Prev Close
$161.58
Open
$164.56
Day's High
$164.65
Day's Low
$161.42
Volume
6,097,069
Avg. Vol
3,827,531
52-wk High
$164.65
52-wk Low
$108.20

Search Stocks
Select another date:

Tue, Oct 28 2014

US STOCKS-Wall St jumps 1 pct, S&P ends above key level

* Indexes up: Dow 1.1 pct, S&P 1.2 pct, Nasdaq 1.8 pct (Updates to close, adds Facebook results after the close)

US STOCKS-Wall St gains as earnings, confidence data beat expectations

* Indexes up: Dow 0.6 pct, S&P 0.7 pct, Nasdaq 1.3 pct (Updates to afternoon trading)

Amgen 2015 outlook tops estimates, no plan to split; shares jump

NEW YORK - Amgen Inc , which has come under investor pressure to split the company, said Tuesday it has no plans to do so and forecast 2015 earnings and revenue well ahead of analysts' projections, sending shares up 5 percent.

UPDATE 3-Amgen 2015 outlook tops estimates, no plan to split; shares jump

NEW YORK, Oct 28 - Amgen Inc, which has come under investor pressure to split the company, said Tuesday it has no plans to do so and forecast 2015 earnings and revenue well ahead of analysts' projections, sending shares up 5 percent.

Amgen 2015 forecast tops Street view; sees cost cuts, share buyback

NEW YORK, Oct 28 - Amgen Inc on Tuesday forecast 2015 earnings and revenue well ahead of Wall Street projections and announced plans to cut costs and increase returns to shareholders through a dividend increase and share repurchases.

Amgen, Sanofi, Ono link with academia on proteins project

LONDON - U.S.-based Amgen, France's Sanofi and Ono Pharmaceutical of Japan have linked with three research institutes to study a super-family of proteins controlling everything from taste to the spread of cancer.

Amgen, Sanofi, Ono link with academia on proteins project

LONDON, Oct 28 - U.S.-based Amgen, France's Sanofi and Ono Pharmaceutical of Japan have linked with three research institutes to study a super-family of proteins controlling everything from taste to the spread of cancer.

Amgen profit tops Wall Street expectations; raises 2014 outlook

- Amgen Inc on Monday reported higher-than-expected third quarter earnings and revenue, even as net profit fell due to a hefty restructuring charge, and the company raised its full-year forecast and the number of job cuts it expects to make.

UPDATE 3-Amgen profit tops Wall Street expectations; raises 2014 outlook

Oct 27 - Amgen Inc on Monday reported higher-than-expected third quarter earnings and revenue, even as net profit fell due to a hefty restructuring charge, and the company raised its full-year forecast and the number of job cuts it expects to make.

BRIEF-Amgen now expects job cuts to exceed 2,900

Oct 27 - Amgen Inc : * Says now expects job cuts to exceed 2,900, up from prior view of 2,400 to

Select another date:
Search Stocks